Safety and Efficacy of realSKIN® to Provide Complete Wound Closure of Burn Wounds as an Alternative to Autografting

Recruiting

Phase 3

Safety and Efficacy of realSKIN® to Provide Complete Wound Closure of Burn Wounds as an Alternative to AutograftingSafety and Efficacy of realSKIN® to Provide Complete Wound Closure of Burn Wounds as an Alternative to Autografting

Sponsor:

XenoTherapeutics, Inc.

Code:

NCT06223269

Conditions

Burns Degree Third

Burn (Disorder)

Burn Degree Second

Thermal Burn

Wound Heal

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Skin Xenotransplant

Autograft(ing)

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-04-01. This information was provided to ClinicalTrials.gov by XenoTherapeutics, Inc. on 2024-10-16.